Terms: = Germ cell tumor AND WT1, WAGR, 7490, ENSG00000184937, WT33, GUD, WIT-2 AND Prognosis
26 results:
1. Predicting the prognosis of glioma patients with TERT promoter mutations and guiding the specific immune profile of immune checkpoint blockade therapy.
Cao W; Lan J; Hu C; Kong J; Xiang L; Zhang Z; Sun Y; Zeng Z; Lei S
Aging (Albany NY); 2024 Mar; 16(6):5618-5633. PubMed ID: 38499392
[TBL] [Abstract] [Full Text] [Related]
2. Long non-coding RNA as a potential diagnostic and prognostic biomarker in melanoma: A systematic review and meta-analysis.
Masrour M; Khanmohammadi S; Fallahtafti P; Hashemi SM; Rezaei N
J Cell Mol Med; 2024 Feb; 28(3):e18109. PubMed ID: 38193829
[TBL] [Abstract] [Full Text] [Related]
3. An immune signature to predict the prognosis of
Cao W; Sun P; Luo S; Zeng Z; Xiao C; Yu W; Lei S
Aging (Albany NY); 2023 Oct; 15(19):10453-10472. PubMed ID: 37812190
[TBL] [Abstract] [Full Text] [Related]
4. Locally advanced choroidal melanoma with favorable molecular prognosis - case report.
Bălăşoiu AT; Ştefănescu-Dima AŞ; Bălăşoiu M; Ciurea RN; Muraru A; Dan AO; Simionescu CE
Rom J Morphol Embryol; 2022; 63(4):645-652. PubMed ID: 36808200
[TBL] [Abstract] [Full Text] [Related]
5. A case of ovarian Teratoma with nephroblastoma presenting abdomen metastasis.
Wu Y; Chu C; Zhang J; Nitish B; Ni J; Xu X
J Clin Lab Anal; 2022 May; 36(5):e24364. PubMed ID: 35349728
[TBL] [Abstract] [Full Text] [Related]
6. Maintenance of wt1 expression in tumor cells is associated with a good prognosis in malignant glioma patients treated with wt1 peptide vaccine immunotherapy.
Yokota C; Kagawa N; Takano K; Chiba Y; Kinoshita M; Kijima N; Oji Y; Oka Y; Sugiyama H; Tsuboi A; Izumoto S; Kishima H; Hashimoto N
Cancer Immunol Immunother; 2022 Jan; 71(1):189-201. PubMed ID: 34089373
[TBL] [Abstract] [Full Text] [Related]
7. Development and validation of a nomogram to predict cancer-specific survival of uveal melanoma.
Zeng Q; Yao Y; Zhao M
BMC Ophthalmol; 2021 May; 21(1):230. PubMed ID: 34030647
[TBL] [Abstract] [Full Text] [Related]
8. Prognostic Nomograms for Primary High-Grade Glioma Patients in Adult: A Retrospective Study Based on the SEER Database.
Yang Y; Yao M; Long S; Xu C; Li L; Li Y; Li G
Biomed Res Int; 2020; 2020():1346340. PubMed ID: 32775408
[TBL] [Abstract] [Full Text] [Related]
9. The importance of IDH1, ATRX and WT-1 mutations in glioblastoma.
Gülten G; Yalçın N; Baltalarlı B; Doğu G; Acar F; Doğruel Y
Pol J Pathol; 2020; 71(2):127-137. PubMed ID: 32729303
[TBL] [Abstract] [Full Text] [Related]
10. Differential Expression of Wilms' tumor Protein in Diffuse Intrinsic Pontine Glioma.
Lee S; Kambhampati M; Yadavilli S; Gordish-Dressman H; Santi M; Cruz CR; Packer RJ; Almira-Suarez MI; Hwang EI; Nazarian J
J Neuropathol Exp Neurol; 2019 May; 78(5):380-388. PubMed ID: 30990879
[TBL] [Abstract] [Full Text] [Related]
11. Deletion of an intronic HIF-2α binding site suppresses hypoxia-induced wt1 expression.
Krueger K; Catanese L; Sciesielski LK; Kirschner KM; Scholz H
Biochim Biophys Acta Gene Regul Mech; 2019 Jan; 1862(1):71-83. PubMed ID: 30468780
[TBL] [Abstract] [Full Text] [Related]
12. [Clinicopathologic features of primary renal neuroendocrine carcinoma].
Wang XH; Lu X; He B; Jiang YX; Yu WJ; Wang H; Zhang W; Li YJ
Zhonghua Bing Li Xue Za Zhi; 2018 Nov; 47(11):851-856. PubMed ID: 30423609
[No Abstract] [Full Text] [Related]
13. [Pathologic features on gonadal changes of sexual developmental disorders in children].
Yi P; Niu HL; Gao Q; Wang FH; Jia W; Chen ZR; Xia JQ; Li LP; Cao Y; Zeng RX
Zhonghua Bing Li Xue Za Zhi; 2018 Jul; 47(7):531-535. PubMed ID: 29996319
[No Abstract] [Full Text] [Related]
14. Atypical teratoid/ rhabdoid tumor, an immunohistochemical study of potential diagnostic and prognostic markers.
Al-Hussaini M; Dissi N; Souki C; Amayiri N
Neuropathology; 2016 Feb; 36(1):17-26. PubMed ID: 26207291
[TBL] [Abstract] [Full Text] [Related]
15. [Neuroendocrine tumors of the kidneys].
Moch H
Pathologe; 2015 May; 36(3):278-82. PubMed ID: 25898936
[TBL] [Abstract] [Full Text] [Related]
16. A subtraction tolerization method of immunization allowed for Wilms' tumor protein-1 (wt1) identification in melanoma and discovery of an antitumor peptide sequence.
Massaoka MH; Matsuo AL; Figueiredo CR; Girola N; Farias CF; Pasqualoto K; Travassos LR
J Immunol Methods; 2014 Dec; 414():11-9. PubMed ID: 25205401
[TBL] [Abstract] [Full Text] [Related]
17. Wilms' tumor 1 is involved in tumorigenicity of glioblastoma by regulating cell proliferation and apoptosis.
Kijima N; Hosen N; Kagawa N; Hashimoto N; Kinoshita M; Oji Y; Sugiyama H; Yoshimine T
Anticancer Res; 2014 Jan; 34(1):61-7. PubMed ID: 24403445
[TBL] [Abstract] [Full Text] [Related]
18. α-type-1 polarized dendritic cell-based vaccination in recurrent high-grade glioma: a phase I clinical trial.
Akiyama Y; Oshita C; Kume A; Iizuka A; Miyata H; Komiyama M; Ashizawa T; Yagoto M; Abe Y; Mitsuya K; Watanabe R; Sugino T; Yamaguchi K; Nakasu Y
BMC Cancer; 2012 Dec; 12():623. PubMed ID: 23270484
[TBL] [Abstract] [Full Text] [Related]
19. Use of (11)C-methionine PET parametric response map for monitoring wt1 immunotherapy response in recurrent malignant glioma.
Chiba Y; Kinoshita M; Okita Y; Tsuboi A; Isohashi K; Kagawa N; Fujimoto Y; Oji Y; Oka Y; Shimosegawa E; Morita S; Hatazawa J; Sugiyama H; Hashimoto N; Yoshimine T
J Neurosurg; 2012 Apr; 116(4):835-42. PubMed ID: 22242671
[TBL] [Abstract] [Full Text] [Related]
20. GSTP1 hypermethylation is associated with reduced protein expression, aggressive disease and prognosis in neuroblastoma.
Gumy-Pause F; Pardo B; Khoshbeen-Boudal M; Ansari M; Gayet-Ageron A; Sappino AP; Attiyeh EF; Ozsahin H
Genes Chromosomes Cancer; 2012 Feb; 51(2):174-85. PubMed ID: 22045684
[TBL] [Abstract] [Full Text] [Related]
[Next]
